Health Care Service will stop reimbursing patients for injectable amniotic-tissue products made by MiMedx Group and promoted for ailments such as hair loss, erectile dysfunction and knee pain.
from WSJ.com: US Business https://ift.tt/2Ms8bFI
via IFTTT
No comments:
Post a Comment